Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients

Aim. To investigate the associations of cell proliferation marker Ki-67 in estrogen receptor (ER) and progesterone receptor (PR) positive (ER+/ PR+) and negative (ER-/PR-) tumors with the ratio of antibodies against estradiol and progesterone (IgA1-E2/IgA1-Pg) in the serum of breast cancer (BC) pati...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. N. Glushkov, E. G. Polenok, S. A. Mun, L. A. Gordeeva, M. V. Kostyanko, A. V. Antonov, P. V. Bayramov, N. E. Verzhbitskaya, G. I. Kolpinskiy
Format:	Article
Language:	Russian
Published:	Kemerovo State Medical University 2023-09-01
Series:	Фундаментальная и клиническая медицина
Subjects:	breast cancer antibodies estradiol progesterone estrogen receptor progesterone receptor ki-67
Online Access:	https://fcm.kemsmu.ru/jour/article/view/750
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients

Similar Items